Literature DB >> 9822326

Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease.

K L Cox1, K M Cox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822326     DOI: 10.1097/00005176-199811000-00015

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  14 in total

Review 1.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Folashade A Jose; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

2.  Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  David N Abarbanel; Scott M Seki; Yinka Davies; Natalie Marlen; Joseph A Benavides; Kathleen Cox; Kari C Nadeau; Kenneth L Cox
Journal:  J Clin Immunol       Date:  2012-10-09       Impact factor: 8.317

Review 3.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

Review 4.  Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.

Authors:  James H Tabibian; Steven P O'Hara; Keith D Lindor
Journal:  Scand J Gastroenterol       Date:  2014-07-03       Impact factor: 2.423

Review 5.  A review of the medical treatment of primary sclerosing cholangitis in the 21st century.

Authors:  Elizabeth C Goode; Simon M Rushbrook
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

6.  Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

Authors:  James H Tabibian; Ahmad H Ali; Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-05

Review 7.  Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).

Authors:  Jochen Mattner
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

Review 8.  Update on pharmacotherapies for cholestatic liver disease.

Authors:  Ahmad H Ali; James H Tabibian; Keith D Lindor
Journal:  Hepatol Commun       Date:  2016-12-21

9.  Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin.

Authors:  Yinka K Davies; Cynthia J Tsay; Dario V Caccamo; Kathleen M Cox; Ricardo O Castillo; Kenneth L Cox
Journal:  Case Rep Transplant       Date:  2013-02-24

Review 10.  Role of the microbiota and antibiotics in primary sclerosing cholangitis.

Authors:  James H Tabibian; Jayant A Talwalkar; Keith D Lindor
Journal:  Biomed Res Int       Date:  2013-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.